https://orcid.org/0000-0002-6502-8464
Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Kaixin Xiong, Peng Yang, Yujia Cui, Jia Li, Yan Li & Boyu Tang. (2023) Research on the Association Between Periodontitis and COPD. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1937-1948.
Read now
Read now
Petra Kristina Jacobson, Leili Lind & Hans Lennart Persson. (2023) The Exacerbation of Chronic Obstructive Pulmonary Disease: Which Symptom is Most Important to Monitor?. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1533-1541.
Read now
Read now
Juan José Soler-Cataluña, José Luis Izquierdo, Mónica Juárez Campo, Antoni Sicras-Mainar & Javier Nuevo. (2023) Impact of COPD Exacerbations and Burden of Disease in Spain: AVOIDEX Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1103-1114.
Read now
Read now
Taeyun Kim, Hyunji Choi, Ju-il Seo, Seung-Jin Kim, Ji-Eun Choi, Minsu Yun & Jihun Kang. (2023) Prevalence, Trend, and Risk Factors for Early Chronic Obstructive Pulmonary Disease: An Analysis of the Nationwide Population-Based Survey from 2010 to 2019 in South Korea. COPD: Journal of Chronic Obstructive Pulmonary Disease 20:1, pages 153-161.
Read now
Read now
Josep Darbà & Meritxell Ascanio. (2023) Incidence and medical costs of chronic obstructive respiratory disease in Spanish hospitals: a retrospective database analysis. Journal of Medical Economics 26:1, pages 335-341.
Read now
Read now
Huanrong Ruan, Hailong Zhang, Zhenzhen Feng, Xuanlin Li, Weihong Han, Yimei Si & Jiansheng Li. (2022) Assessment of Completeness of Reporting in Randomized Controlled Trials of Acupuncture Therapy for Chronic Obstructive Pulmonary Disease. International Journal of General Medicine 15, pages 5335-5348.
Read now
Read now
Yanqing Gong, Qiying Chen & Yin Zhang. (2022) The Role of the Clinical Pharmacist on the Health Outcomes of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1863-1870.
Read now
Read now
Xuetao Zeng, Hongfeng Yang, Yan Yang, Xinnan Gu, Xiuqin Ma & Taofeng Zhu. (2021) Associations of Clinical Characteristics and Intestinal Flora Imbalance in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients and the Construction of an Early Warning Model. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3417-3428.
Read now
Read now
Haihong Zhang, Fang Wu, Hongli Yi, Dongjuan Xu, Nana Jiang, Yonghong Li, Ming Li & Kefang Wang. (2021) Gender Differences in Chronic Obstructive Pulmonary Disease Symptom Clusters. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1101-1107.
Read now
Read now
Anders Løkke, Peter Lange, Jesper Lykkegaard, Rikke Ibsen, Maria Andersson, Sofie de Fine Licht & Ole Hilberg. (2021) Economic Burden of COPD by Disease Severity – A Nationwide Cohort Study in Denmark. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 603-613.
Read now
Read now
John N Pritchard. (2020) The Climate is Changing for Metered-Dose Inhalers and Action is Needed. Drug Design, Development and Therapy 14, pages 3043-3055.
Read now
Read now
Articles from other publishers (43)
R. Chad Wade, Takudzwa Mkorombindo, Sharon X. Ling, Erika. S. Helgeson, David M. MacDonald, Krystle Pew, Helen Voelker, Vera Bittner, Ken M. Kunisaki, Matthew R. Lammi & Mark. T. Dransfield. (2023) Association between P-pulmonale and respiratory morbidity in COPD: a secondary analysis of the BLOCK-COPD trial. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Sana Younas, Saeeda Khanum & Azher Hameed Qamar. (2023) Decision making among residents in training of obstetrics and gynecology: A qualitative exploration in Pakistani context. PLOS ONE 18:11, pages e0287592.
Crossref
Crossref
Jeroen R.J.H. Gruiskens, Liesbeth F.M. van Hoef, Maurice M. Theunissen, Annemie M. Courtens, Annerika H.M. Gidding-Slok, Onno C.P. van Schayck & Marieke M.H.J. van den Beuken–van Everdingen. (2023) Recommendations for Improving Chronic Care in Times of a Pandemic Based on Patient Experiences. Journal of the American Medical Directors Association.
Crossref
Crossref
Ashwani Verma, Ashok Behera, Rohitashwa Kumar, Nachiket Gudi, Ashish Joshi & KM Monirul Islam. (2023) Mapping of digital health interventions for the self-management of COPD: A systematic review. Clinical Epidemiology and Global Health 24, pages 101427.
Crossref
Crossref
Shan Zhong, Chengshui Chen, Li Yang, Meiling Jin, Yiming Zeng, Gang-Ming Zou, Qingying Zhang & Yun Wang. (2023) Identification of circRNA-associated ceRNA networks in peripheral blood mononuclear cells as potential biomarkers for chronic obstructive pulmonary disease. Bioscience Reports 43:10.
Crossref
Crossref
Stephanie A. Robinson, Marilyn L. MoyJohn P. Ney. (2023) Value of Information Analysis of a Web-Based Self-Management Intervention for Chronic Obstructive Pulmonary Disease. Telemedicine and e-Health.
Crossref
Crossref
Dhiraj Agarwal. (2023) COPD generates substantial cost for health systems. The Lancet Global Health 11:8, pages e1138-e1139.
Crossref
Crossref
Simiao Chen, Michael Kuhn, Klaus Prettner, Fengyun Yu, Ting Yang, Till Bärnighausen, David E Bloom & Chen Wang. (2023) The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling study. The Lancet Global Health 11:8, pages e1183-e1193.
Crossref
Crossref
Yongyi Peng, Zhongping Wu, Kuiqing Lin, Ruibo Huang, Jinhai Huang, Junfeng Lin, Shubing Chen, Jinping Zheng & Yi Gao. (2023) Exploration of quality criteria for the detection of peak inspiratory flow under different resistance conditions. Technology and Health Care, pages 1-10.
Crossref
Crossref
Seyyed-Hadi Ghamari, Farnam Mohebi, Mohsen Abbasi-Kangevari, Soheil Peiman, Besharat Rahimi, Naser Ahmadi, Yousef Farzi, Shahedeh Seyfi, Nazila Shahbal, Mitra Modirian, Mehrdad Azmin, Hossein Zokaei, Maryam Khezrian, Roya Sherafat, Mohammad-Reza Malekpour, Shahin Roshani, Negar Rezaei, Mohammad Javad Fallahi, Maryam Haddadzadeh Shoushtari, Zahra Akbaripour, Shahab Khatibzadeh & Saeid Shahraz. (2023) Patient experience with chronic obstructive pulmonary disease: a nationally representative demonstration study on quality and cost of healthcare services. Frontiers in Public Health 11.
Crossref
Crossref
Hua Ye, Beibei He, Yujie Zhang, Ziwei Yu, Yifan Feng, Chuanbiao Wen, Chongcheng Xi & Quansheng Feng. (2023) Herb-symptom analysis of Erchen decoction combined with Xiebai powder formula and its mechanism in the treatment of chronic obstructive pulmonary disease. Frontiers in Pharmacology 14.
Crossref
Crossref
Charles Yan, Jeff Round, Ilke Akpinar, Chantal E. Atwood, Lesly Deuchar, Mohit Bhutani, Richard Leigh & Michael K. Stickland. (2023) Cost Analysis of a Transition Care Bundle Compared with Usual Care for COPD Patients Being Discharged from Hospital: Evaluation of a Randomized Controlled Trial. PharmacoEconomics - Open 7:3, pages 493-505.
Crossref
Crossref
Miquéias Lopes-Pacheco & Patricia R. M. Rocco. (2023) Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases. Frontiers in Pharmacology 14.
Crossref
Crossref
Ho Jin Cho, Jungmi Chae, Sang‐Heon Yoon & Dong‐Sook Kim. (2022) Factors related to polypharmacy and hyper‐polypharmacy for the elderly: A nationwide cohort study using National Health Insurance data in South Korea. Clinical and Translational Science 16:2, pages 193-205.
Crossref
Crossref
Muhammad Fawad Rasool, Anees ur Rehman, Irfanullah Khan, Muhammad Latif, Imran Ahmad, Sadia Shakeel, Muhammad Sadiq, Khezar Hayat, Shahid Shah, Waseem Ashraf, Abdul Majeed, Iltaf Hussain & Rabia Hussain. (2023) Assessment of risk factors associated with potential drug-drug interactions among patients suffering from chronic disorders. PLOS ONE 18:1, pages e0276277.
Crossref
Crossref
Thanh Thuy Phan, Van Giap Vu, Le-Thi Tuyet-Lan, Viet Nhung Nguyen & Quy Chau Ngo. (2023) Medication Adherence Assessment and Cost Analysis of COPD Treatment Under Out-Patient Clinic in Vietnam. Health Services Insights 16, pages 117863292311775.
Crossref
Crossref
Huanrong Ruan, Hailong Zhang, Jiajia Wang, Hulei Zhao, Weihong Han & Jiansheng Li. (2023) Readmission rate for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respiratory Medicine 206, pages 107090.
Crossref
Crossref
Yaxin Wu, Xin Di, Min Zhao, Haoran Li, Li Bai & Ke Wang. (2022) The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease. Immunity, Inflammation and Disease 10:12.
Crossref
Crossref
Hamidreza Feizi, Mahasti Alizadeh, Seyed Aria Nejadghaderi, Maryam Noori, Mark J. M. Sullman, Javad Ahmadian Heris, Ali-Asghar Kolahi, Gary S. Collins & Saeid Safiri. (2022) The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990–2019. Respiratory Research 23:1.
Crossref
Crossref
Jiaxi Rang, Liming Peng, Long Wen, Zhiguo Zhou, You Xia, Chaoying Xie, Ting Xie & Jing Tan. (2022) The Effect of Teach-Back Combined with King Interactive Standard Mode on the Life of COPD Patients. Contrast Media & Molecular Imaging 2022, pages 1-8.
Crossref
Crossref
Guixiang Zhao, Xuanlin Li, Siyuan Lei, Hulei Zhao, Hailong Zhang & Jiansheng Li. (2022) Prevalence of lung cancer in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Frontiers in Oncology 12.
Crossref
Crossref
Alexandrosz Czira, Victoria Banks, Gema Requena, Robert Wood, Theo Tritton, Rosie Wild, Chris Compton, Maria Duarte & Afisi S Ismaila. (2022)
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β
2
-agonist dual therapy in a primary care setting in England
. BMJ Open Respiratory Research 9:1, pages e001243.
Crossref
Crossref
Emilie Lambourg, Carole Siani & Laure de Preux. (2022) Use of a high-volume prescription database to explore health inequalities in England: assessing impacts of social deprivation and temperature on the prescription volume of medicines. Journal of Public Health 30:9, pages 2231-2242.
Crossref
Crossref
Arwel W Jones, Joanne E McKenzie, Christian R Osadnik, Elizabeth Stovold, Narelle S Cox, Angela T Burge, Aroub Lahham, Joanna YT Lee, Mariana Hoffman & Anne E Holland. (2022) Non-pharmacological interventions for the prevention of hospitalisations in stable chronic obstructive pulmonary disease: component network meta-analysis. Cochrane Database of Systematic Reviews 2022:7.
Crossref
Crossref
Michelle Vega-Olivo, David M.G. Halpin, MeiLan K. Han, Nicola A. Hanania, Ravi Kalhan, David A. Lipson, Neil MacIntyre, Dawn Midwinter, Marjorie Stiegler, Corinne Young, Fernando J. Martinez & Gerard J. Criner. (2022) Best Practice Management of Patients With Chronic Obstructive Pulmonary Disease: A Case-Based Review. The Journal for Nurse Practitioners 18:7, pages 730-735.
Crossref
Crossref
Shan Zhong, Li Yang, Naijia Liu, Guangkeng Zhou, Zhangli Hu, Chengshui Chen & Yun Wang. (2022) Identification and validation of aging-related genes in COPD based on bioinformatics analysis. Aging 14:10, pages 4336-4356.
Crossref
Crossref
Zia Ul Mustafa, Muhammad Salman, Irsa Jamal, Mahpara Kanwal, Muhammad Bilal Riaz, Syed Shahzad Hasan & Amer Hayat Khan. (2022) A pharmacist-led educational intervention to improve nebulization-related knowledge and practices of nursing staff: a pre–post interventional study from Pakistan. Drugs & Therapy Perspectives 38:4, pages 194-200.
Crossref
Crossref
Weihong Han, Minghang Wang, Yang Xie, Huanrong Ruan, Hulei Zhao & Jiansheng Li. (2022) Prevalence of Pulmonary Embolism and Deep Venous Thromboembolism in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Zhao Yang, Man Ki Kwok & Catherine Mary Schooling. (2022) Do deaths from competing risks influence COPD patterns in China and high socio-demographic index countries?: a cross-sectional analysis of summary statistics from the Global Burden of Disease Study 2017. BMJ Open 12:3, pages e050080.
Crossref
Crossref
Celia Gutiérrez Villegas, María Paz-Zulueta, Manuel Herrero-Montes, Paula Parás-Bravo & María Madrazo Pérez. (2021) Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review. Health Economics Review 11:1.
Crossref
Crossref
Anees ur Rehman, Sohail Ayaz Muhammad, Zermina Tasleem, Alyaa Alsaedi, Mamoona Dar, Muhammad Omer Iqbal, Muhammad Fawad Rasool, Shahid Shah, Ghulam Abbas, Sadia Shakeel & Khezar Hayat. (2021) Humanistic and socioeconomic burden of COPD patients and their caregivers in Malaysia. Scientific Reports 11:1.
Crossref
Crossref
Xueyi Deng, Fuqin Kang, Xueyin Chen, Jiaqi Lai, Xuanchen Guan, Xinfeng Guo & Shaonan Liu. (2021) Comparative Effectiveness and Safety of Seven Qi-Tonifying Chinese Medicine Injections for AECOPD Patients: A Systematic Review and Network Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-15.
Crossref
Crossref
John P. NeyStephanie A. RobinsonCaroline R. RichardsonMarilyn L. Moy. (2021) Can Technology-Based Physical Activity Programs for Chronic Obstructive Pulmonary Disease Be Cost-Effective?. Telemedicine and e-Health 27:11, pages 1288-1292.
Crossref
Crossref
Anoma Santiworakul, Nitita Piya-amornphan & Netchanok Jianramas. (2021) A Home-Based Multimedia Pulmonary Rehabilitation Program Improves Clinical Symptoms and Physical Performance of Patients with Chronic Obstructive Pulmonary Disease. International Journal of Environmental Research and Public Health 18:21, pages 11479.
Crossref
Crossref
Svetlana I. Ovcharenko & Andrey S. Belevskiy. (2021) Benefit/risk ratio profile of single inhaler triple therapy for сhronic obstructive pulmonary disease patients. PULMONOLOGIYA 31:5, pages 645-652.
Crossref
Crossref
Glenn Leemans, Jan Taeymans, Paul Van Royen & Dirk Vissers. (2021) Respiratory physiotherapy interventions focused on exercise training and enhancing physical activity levels in people with chronic obstructive pulmonary disease are likely to be cost-effective: a systematic review. Journal of Physiotherapy 67:4, pages 271-283.
Crossref
Crossref
E. A. Orlova, A. R. Umerova, I. P. Dorfman, M. A. Orlov & M. A. Abdullaev. (2021) ЕSTIMATION OF SOCIO-ECONOMIC BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOR A 5-YEAR PERIOD: A REGIONAL ASPECT. Pharmacy & Pharmacology 9:2, pages 130-138.
Crossref
Crossref
Anees ur Rehman, Shahid Shah, Ghulam Abbas, Sabariah Noor Harun, Sadia Shakeel, Rabia Hussain, Mohamed Azmi Ahmad Hassali & Muhammad Fawad Rasool. (2021) Assessment of risk factors responsible for rapid deterioration of lung function over a period of one year in patients with chronic obstructive pulmonary disease. Scientific Reports 11:1.
Crossref
Crossref
Linda Elowsson Rendin, Anna Löfdahl, Måns Kadefors, Zackarias Söderlund, Emil Tykesson, Sara Rolandsson Enes, Jenny Wigén & Gunilla Westergren-Thorsson. (2021) Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases. Frontiers in Pharmacology 12.
Crossref
Crossref
Leila Karimi, Lies Lahousse, Phebe De Nocker, Bruno H. Stricker, Guy G. Brusselle & Katia M.C. Verhamme. (2021) Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study. ERJ Open Research 7:2, pages 00624-2020.
Crossref
Crossref
Xia Ma, Yanping Wu, Ling Zhang, Weilan Yuan, Li Yan, Sha Fan, Yunzhi Lian, Xia Zhu, Junhui Gao, Jiangman Zhao, Ping Zhang, Hui Tang & Weihua Jia. (2020) Comparison and development of machine learning tools for the prediction of chronic obstructive pulmonary disease in the Chinese population. Journal of Translational Medicine 18:1.
Crossref
Crossref
Muhammad Fawad Rasool, Anees ur Rehman, Imran Imran, Sameen Abbas, Shahid Shah, Ghulam Abbas, Irfanullah Khan, Sadia Shakeel, Mohamed Azmi Ahmad Hassali & Khezar Hayat. (2020) Risk Factors Associated With Medication Errors Among Patients Suffering From Chronic Disorders. Frontiers in Public Health 8.
Crossref
Crossref
Takako Eguchi Nakajima, Kensei Yamaguchi, Narikazu Boku, Ichinosuke Hyodo, Junki Mizusawa, Hiroki Hara, Tomohiro Nishina, Takeshi Sakamoto, Kohei Shitara, Katsunori Shinozaki, Hiroshi Katayama, Shinichiro Nakamura, Kei Muro & Masanori Terashima. (2020) Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G). Gastric Cancer 23:4, pages 677-688.
Crossref
Crossref